Push to revitalise antibiotics research
The global pharmaceutical industry is being called on to pay for a $2bn (£1.3bn) innovation fund to revitalise research into antibiotics.
In return, there would be guaranteed payments to companies who produced vitally needed new antibiotics.
There are currently very few new antibiotics in development amid a global spread of resistant bacteria.
Fergus Walsh reports.
14 May 2015
- From the section Health